San Francisco, CA, United States of America

John G Matthews

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by John G Matthews in Asthma Treatment

Introduction

John G Matthews is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of asthma. With a total of 3 patents, Matthews has focused on innovative methods that target specific pathways involved in asthma and related disorders.

Latest Patents

Matthews' latest patents include a groundbreaking method of treating asthma using an IL-13 antibody. This patent outlines methods for diagnosing and treating disorders related to TH2 inhibition, which includes asthma. Additionally, he has developed methods for selecting or identifying patients who may benefit from therapeutic agents that inhibit the TH2 pathway. Another patent focuses on diagnosis and treatments relating to TH2 inhibition, further emphasizing his commitment to advancing asthma treatment.

Career Highlights

John G Matthews is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Genentech has allowed him to collaborate with other experts in the field, enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Joseph R Arron and Richard W Erickson. Their collaboration has likely contributed to the development of effective treatments and diagnostic methods in the realm of asthma and TH2-related disorders.

Conclusion

John G Matthews stands out as an influential inventor in the medical field, particularly in asthma treatment. His innovative patents and work at Genentech, Inc. reflect his dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…